
Ep 38 - HIMS WEEK IN REVIEW: Bloomberg, WaPo, Canada, Blood Tests, Nighthawk, and 38% Short Interest 🤯
Hims House
00:00
Corporate Turbulence: The HIMS and Novo Partnership Breakdown
This chapter analyzes the recent partnership termination between HIMS and Novo, detailing the events leading to the deal and the ensuing fallout. The speakers explore the impact of internal dynamics at Novo, the implications of potential lawsuits, and the timing of strategic decisions. Additionally, there is a reflection on the importance of this partnership for HIMSS's future in healthcare innovation.
Transcript
Play full episode